Introduction
Renal sodium retention in cirrhosis is considered by many to be a response to hypovolemia resulting from formation of ascites (1) (2) (3) (4) (5) . Furthermore, the suggestion has been made that a decrease in plasma volume may also account for the * Submitted for publication November 28, 1966 ; accepted April 20, 1967. Supported by research grant HE09316 from the National Institutes of Health, U. S. Public Health Service.
functional type of renal failure that is being recognized with increasing frequency in cirrhotic patients with ascites (6, 7) . Even though the values for plasma volume in cirrhosis with ascites have been reported as elevated (8) (9) (10) (11) (12) (13) (14) , it has been postulated that this elevation is due to distention of the splanchnic bed and hepatic lymphatics, obscuring a decrease in the nonportal or "effective" plasma volume (2, 15) . It is, of course, possible that plasma volume measurements in ascitic patients are artifactually high because of leakage of the albumin label into the ascites or hepatic lymph during mixing. Although significant leakage into the ascites during the period required for plasma 1297 volume measurement has been discounted (16, 17) , no assessment has yet been made of the degree of leakage into the lymph space.
In this paper we reconfirm the validity of the elevated plasma volume found in the ascitic cirrhotic patient by comparing measurements in a large population of cirrhotic patients both with and without ascites and, therefore, with and without clinical evidence of plasma leakage. Furthermore, our results indicate that the degree of leakage of albumin-'31I from the plasma into the lymph space drained by the thoracic duct is negligible in accounting for this elevation. Finally, evidence will be presented to support portal hypertension as the cause of the elevated plasma volume in cirrhosis.
Methods
One hundred seventy-four patients were studied. Plasma volume was measured simultaneously with albumin-1'I-and '1Cr-labeled red cells in 150 patients and with albumin-"1'I alone in 24 patients. Twenty-four (16 male, 8 female) were control patients, most of whom were semiambulatory and convalescing from various orthopedic procedures; 63 (44 male, 19 female) had cirrhosis without ascites; 34 (22 male, 12 female) had cirrhosis with ascites; 48 (33 male, 15 female) had cirrhosis and an end-to-side or side-to-side portacaval anastomosis for the relief of portal hypertension (14 of these patients had coexisting ascites despite documented patency of the shunt during life or at autopsy in five); 10 (6 male, 4 female) did not have cirrhosis but had a variety of surgical portal-systemic venous shunts for unexplained portal hypertension or portal hypertension associated with partial or complete extrahepatic portal venous occlusion (18) ; and 15 (13 male, 2 female) had cirrhosis and ascites complicated by functional renal failure (6, (19) (20) (21) . Twenty-two of the 63 patients without ascites and one of the 34 patients with ascites had bled from esophageal varices several months before plasma volume measurement and were awaiting portacaval shunt surgery when plasma volume was measured. Plasma volume was measured by albumin-"'I alone in 21 of these patients. Repeat measurements with albumin-'I were made in 18 patients 6 months after end-to-side portacaval anastomosis, and the values are included in the mean plasma volume of the group of 34 patients with portacaval anastomoses without ascites. Almost all patients with cirrhosis had a history of chronic alcoholism, and moderate to advanced liver disease was present in all as judged by needle or surgical liver biopsy in 119, necropsy in 10 who had not undergone biopsy before death, and physical examination and standard biochemical tests in all patients. All patients with ascites were on a diet containing 20 mEq of sodium daily when plasma volume was measured.
For the measurement of red cell volume, 30 ml of venous blood from each patient was labeled with 100 ,Ac 51Cr at room temperature in sterile containers with ACD anticoagulant' added. The reaction was stopped after 30 minutes by adding 50 mg ascorbic acid (22) , and a weighed 20-ml unwashed sample was returned intravenously. After 30 minutes, blood was withdrawn from the opposite arm and oxalated, and 1-ml samples of whole blood and plasma were weighed and counted in a scintillation well counter. The red cell volume was calculated as recommended by Silver (23), using microhematocrit readings determined by the method of McGovern, Jones, and Steinberg (24) . The hematocrit was corrected for trapped plasma by multiplying each reading by 0.96 (25) ; to convert whole blood weight to volume, the specific gravity of each specimen was determined by the copper sulfate technique (26) . In order to calculate plasma volume from the red cell mass, we corrected the peripheral venous hematocrit for trapped plasma and for the "total body": peripheral venous hematocrit ratio, which was arbitrarily taken to be 0.91 in each patient (27) . In fact, if our plasma volume measurements with albumin-"I11 are accurate, this ratio is highly variable and its mean is less than 0.91 in patients with cirrhosis, as will be discussed below.
For the direct measurement of plasma volume, a background reading, which was always negligible, was taken on the 30-minute 51Cr-labeled plasma sample, and approximately 20 ,c of albumin-"31I was injected intravenously when the 30-minute sample was drawn. A 2-ml calibrated syringe was used for injection, and an identical amount of albumin-"1'I was inj ected into an albumincoated water-filled 2-L volumetric flask. A single sample of blood was withdrawn 20 minutes after the intravenous administration of albumin-"1I, and duplicate 1-ml samples of plasma were weighed and counted and a single 1-ml sample of standard was weighed and counted in duplicate, each for 6 minutes or 10,000 counts in a well scintillation counter. For the conversion of the plasma weight to volume, the specific gravity of plasma was assumed to be 1.030.
Because of the distorted weight in patients with cirrhosis and ascites, plasma volume and red cell volume were expressed in all patients in milliliters per kilogram based on ideal weight, calculated according to the formula of Lorentz (28), P = T-100-(T-150)/4, in which P is the ideal weight in kilograms and T is the height in centimeters. The mean ideal weights for the control and study patients were not significantly different, as indicated in Table I (29) .
In six patients with ascites, the plasma volume obtained with a single 20-minute sample was compared with that obtained by extrapolating the logarithm of disappearance of activity over 60 minutes to zero time. Although slightly but consistently higher values were obtained with the 20-minute sample, as expected (mean 2,150 + 155 ml The mean plasma volume, determined with
The method of Bradley, Marks, Reynell, and Meltzer albumin-1311, for the control patients was 42 + 1.6 (33) for measuring the normal circulating splanchnic ml per kg, which is similar to the mean plasma plasma volume in man was adapted to measure the vol-volume of a group of normal men and women studume of the lymph space drained by the thoracic duct in six patients with cirrhosis undergoing thoracic duct drain-ied by Steinfeld (34) and for normal men studied age for the treatment of ascites. In Bradley's method for by Berson (16) . For patients with cirrhosis with determining the splanchnic volume, the appearance of in-and without ascites, mean plasma volume was travenously injected albumin-"'I is measured in blood 55 + 1.9 and 57 + 1.4 ml per kg, respectively. leaving the splanchnic system in the hepatic vein, and its For patients with cirrhosis and portacaval anastoappearance and decline are measured in blood entering the moses with and without ascites, it was 51 ± 3.0 splanchnic system represented by activity in the brachial or femoral artery. Measurements are continued until and 54 ± 1.6 ml per kg, respectively; for patients equilibrium is reached, as indicated by the equivalence of without cirrhosis but with portal-systemic venous activity in the two vessels. The number of counts in the anastomoses, it was 49 ± 1.9 ml per kg. splanchnic bed at equilibrium is found by determining the Compared to the mean plasma volume for the control patients, the mean plasma volume (albumin-1311) for patients with cirrhosis and ascites was significantly elevated (p < 0.0001). For patients with cirrhosis but without ascites, the mean plasma volume was also significantly elevated (p < 0.0001) and not different from the value for patients with ascites (p = 0.40). Also, in patients with cirrhosis who had portacaval anastomoses without ascites, and who presumably had a decrease in intrahepatic as well as splanchnic congestion as a result of this operation, the mean plasma volume was significantly elevated (p < 0.0001). This elevation occurred even in those patients with side-to-side portacaval anastomoses, which are thought to decongest the liver maximally (35, 36) (Figure 1 ). Those 14 patients with cirrhosis who had portacaval anastomoses proven to be patent at autopsy in four and by catheterization in one, yet who had coexisting ascites, also had an elevated mean plasma volume (51 + 3.0 ml per kg, p < 0.01) (Figure 1 ).
The red cell volume was slightly lower than normal in our patients with cirrhosis with and without ascites (p < 0.001 and < 0.01, respectively), and it is possible that part of the plasma volume elevation in these patients was a compensatory response to prevent hypovolemia. However, the whole blood volume, which is the sum of the plasma volume (albumin-131I) and the red cell volume (51Cr) should account for such a compensatory increase in plasma volume (37) . Since the control whole blood volume was 65 + 2.0 ml per kg and that of patients with cirrhosis with and without ascites 74 + 2.1 and 74 + 1.8 ml per kg, respectively, (p < 0.01 and < 0.001, respectively), it seems safe to conclude that the plasma volume is elevated in patients with cirrhosis for reasons other than anemia. Furthermore, the patients with portacaval shunts without ascites had a normal red cell volume (24 + 1.2 ml per kg, p = 0.48), yet still had an elevated plasma and whole blood volume (p < 0.0001 and < 0.001, respectively).
The mean values for plasma, red cell, and whole blood volume in patients without cirrhosis but with surgical portal-systemic venous anastomoses were 49 + 1. kg,3 respectively) are probably due to an abnormally low whole body: peripheral venous hematocrit ratio in cirrhosis, as will be discussed below.
Evidence against the elevated plasma volume being an artifact due to leakage of albumin-131I from the plasma during mixing Leakage into ascites. Ascites radioactivity was simultaneously measured with that of the plasma in 10 patients with cirrhosis 20 minutes after the intravenous administration of albumin-131I. Three of the patients had ascites complicated by functional renal failure, two had patent end-to-side portacaval anastomoses, and the remainder had 3 These latter two means differ from those in Table I because they do not include the values of those patients whose plasma volumes were measured by albumin-"'I alone. uncomplicated ascites. The per cent activity of the ascites with respect to plasma for each of these patients is recorded in Table II ; for the 10 patients the mean was 0.6 0.16%. Assuming that the volume of ascites was as high as five times the plasma volume (e.g., 15 L of ascites with a 3-L plasma volume), the total injected activity in the ascites at 20 minutes would be approximately 3%o.
Leakage into lymph. The data obtained during sampling of thoracic duct lymph after the intravenous injection of albumin-311I are recorded in Table III , and a representative equilibrium curve is shown in Figure 2 Table  IV . On the average it represented only 0.8%o of this activity. The altered total body: peripheral venous hematocrit ratio in cirrhosis. The total body hematocrit can be determined by adding the 51Cr-labeled red cell volume to the albumin-131I plasma volume to obtain the whole blood volume and by dividing this sum into the 51Cr-labeled red cell volume. When this ratio in turn is divided by the peripheral hematocrit corrected for trapped plasma, the resultant ratio has been found to vary from 0.89 to 0.92 in various groups of normal subjects (27) . The mean ratio was 0.88 in our control patients and 0.91 in those 10 patients with portal-systemic shunts without cirrhosis. However, it was low in all patients with cirrhosis ( Table I ), indicating that the normal preponderance of whole body plasma to red cells with respect to peripheral venous blood is exaggerated in cirrhosis. Larsen, Winkler, and Tygstrup have found that the ratio of hepatic plasma volume to hepatic red cell volume in patients with cirrhosis and end-to-side portacaval anastomoses accounts for only 20% of this preponderance (41) . Low body: venous hematocrit ratios have been reported in other diseases (42, 43) , and unless taken into account in calculating total plasma volume from red cell volume and peripheral hematocrit, erroneously lower values for plasma volume will be obtained with the 51Cr-labeled red cell method.
Plasma volume in functional renal failure
Plasma volume was measured in 15 patients who had cirrhosis with ascites and what has been called, because of the lack of any consistent renal histopathology, "functional" renal failure (6, (19) (20) (21) . Although the pathogenesis of this renal failure is poorly understood, Vesin has proposed that it develops as a result of decreased renal perfusion when effective plasma volume is reduced. He feels that during an ill-defined stage of cirrhosis with ascites, patients can no longer recoup their usually expanded plasma volume; in his experience, in patients seen for the first time at the stage of renal failure, the plasma volume was never increased, but corresponded to normal figures or was even below normal (6). Pequignot, Combrisson, Viallet, and Caroli have found that compared to that in a control group of 63 patients, the mean blood volume was lower in a group of 74 cirrhotic patients with hyperazotemia associated with a variety of problems such as gastrointestinal bleeding, peritonitis, and sepsis, and with diuretic therapy and paracentesis (7). There was a mean decrease of 9 + 1.9 ml per kg (p = 0.01, Student t test) in plasma volume with albumin-131I before and 6 months after portacaval shunt in 18 patients (Figure 3) . The mean * values before and after shunt were 64 + 2.8 and 55 + 1.4 ml per kg, respectively. There was a mean rise in hematocrit of 2.9 + 1.3% (p < 0.05).
Comparison of wedged hepatic venous pressure and plasma volume There was a definite correlation between wedged hepatic venous pressure and plasma volume measured with albumin-'111 (r = + 0.501, p < 0.05).
The individual values are plotted in Figure 4 . The 15 patients studied here appeared to develop renal failure as part of the natural history of cirrhosis. All had ascites, and 14 died and were found to have normal kidneys at necropsy. None had suffered gastrointestinal hemorrhage before the recognition of renal failure, none had undergone paracentesis, and only four had undergone drug-induced diuresis, as judged by weight loss during a preceding period, which could reasonably be related to the renal failure. All were on a diet containing 20 mEq of sodium daily when plasma volume was measured. The mean plasma volume for the 15 patients, using albumin-131I was 52 + 2.6 ml per kg, which is significantly elevated from that of the control patients (42 1 The use of ideal weight based on height might have biased our results in favor of an increase in plasma volume in cirrhosis with ascites, if the mean ideal weight for these patients constitutes an underestimation of dry weight. However, this appears unlikely because of the large number of patients studied, which minimizes individual variation in dry weight, and because there was no appreciable difference in the mean ideal weights of these patients and the control patients. Others have also found a slow exchange of albumin between plasma and ascites in cirrhosis (16, 17, 30, 44) . Although the lymph space we have calculated may be smaller than previously advanced concepts of its magnitude in cirrhosis (15, 45) , we believe it is probably a reasonable, though approximate, figure. Even if there were pathways other than the thoracic duct for return of lymph to the plasma (46, 47) , such pathways would create a situation in which the proposed method for measuring the lymphatic space would produce a spuriously elevated, not reduced, volume.
From the foregoing comparison of plasma volume in patients with and without ascites, and from the direct assessment of the degree of leakage of albumin-1311 into ascites and lymph during mixing, we have concluded that the elevated plasma volume in cirrhosis with ascites is real, not an artifact due to leakage of albumin-131I from the plasma during mixing.
Perera (8) and others (10, 11) have proposed that the elevated plasma volume in hepatic cirrhosis is due to an expanded portal venous bed, which necessitates an expansion of the plasma volume to fill it. Decompression of this hypertensive portal system by portacaval anastomosis should then theoretically return the plasma volume to normal. However, all investigators find the plasma volume to be elevated in the presence of a portacaval shunt, whether end-to-side (12, 28) or side-to-side (48 (50) .
Our own data suggest that portal hypertension is the cause of the plasma volume increase in cirrhosis. The relief of portal hypertension by portacaval anastomosis was accompanied by a definite fall in plasma volume, although not to normal values. Other workers have also measured plasma volume before and after portal decompression, and have obtained similar results. Combrisson, Bonnet, and Hivet (28), using chromium-labeled red cells and measuring plasma volume indirectly from peripheral venous hematocrit, found the mean plasma volume to be 139% of normal before shunt in five patients with cirrhosis, and 136% after endto-side portacaval shunt. Even, Nicollo, Benhamou, and Fauvert (51), also using chromiumlabeled red cells, found no statistical difference in the mean whole blood volume in 12 patients with cirrhosis before and after end-to-side portacaval shunt. However, if the plasma volume is calculated in each of their patients from the peripheral hematocrit, there was a mean decrease of 9 + 3.4%, which is statistically significant (p < 0.03, Student t test). In seven of 12 of McDermott's patients undergoing "double barrel" or side-to-side portacaval shunt for the treatment of ascites (48) , plasma volume can be related to ideal body weight based on height. When so expressed, the mean values before and after shunt were 68 + 6 and 51 + 5 ml per kg.
Because portal hypertension and bleeding from esophageal varices seem intimately related, our finding of an unusually high plasma volume in patients undergoing portacaval shunt because of bleeding varices (64 ± 2.8 ml per kg) also supports a causal relationship between portal hypertension and plasma volume elevation. Of the group of 63 patients with cirrhosis free of ascites, 22 had bled from esophageal varices several months before plasma volume was measured. The mean plasma volume for these 22 patients was 63 + 2.0 ml per kg compared to 53 ± 1.4 for the remaining 41 patients (p < 0.0001) who had not bled from varices.
Finally, the finding of a positive correlation between wedged hepatic venous pressure and plasma volume, though not providing proof of a causal relationship between portal hypertension and plasma volume elevation in cirrhosis, adds additional support for this concept.
If we accept portal hypertension as the cause for the increased plasma volume in cirrhosis, we must account for our data and those of others (12, 28, 48) , which show hypervolemia after portacaval anastomosis. The following three possibilities occur to us: 1) The portacaval anastomosis, by decreasing hepatic blood flow, might keep the plasma volume from falling to normal. Evidence has been presented recently to show that hepatic degradation of aldosterone is dependent on liver blood flow (52) (53) (54) , and it is possible that a reduction in hepatic blood flow produced by portacaval anastomosis of either the end-to-side or side-to-side variety (36) could elevate the plasma aldosterone concentration sufficiently to keep the plasma volume expanded.
2) The portacaval anastomosis, by allowing a relatively large flow of blood through an area of low resistance, may be acting like a large arteriovenous fistula and may thus provide an alternative reason for continuation of plasma volume expansion despite portal venous decompression.
Either of these explanations might account for the increased plasma volume in our 10 noncirrhotic patients who had a variety -of portal-systemic venous anastomoses for the relief of portal hypertension. The mean values by the albumin-131I and 51Cr-labele red cell techniques were 49 + 1.9 and 49 + 1.9 ml per kg, respectively, which are significantly elevated above the values of the control patients.
3) Increased intrahepatic pressure may be a stimulus for aldosterone secretion, as proposed by Orloff and co-workers (55) , and the degree of intrahepatic pressure elevation that remains after portacaval shunt (32) may be a sufficient stimulus for continued plasma volume expansion, despite complete relief of portal hypertension by the shunt.
